Glenmark Pharma to divest 75% stake in life sciences unit for $680m

Glenmark Pharmaceuticals has signed a definitive agreement for the divestiture of a 75% stake in Glenmark Life Sciences for $679.85m.

Sep 23, 2023 - 20:00

Glenmark Pharma to divest 75% stake in life sciences unit for $680m

Glenmark Pharmaceuticals has signed a definitive agreement for the divestiture of a 75% stake in Glenmark Life Sciences for $679.85m.

Read the original article

Tags:

Previous Article

Novo Holdings acquires biopharma company Paratek for $462m

Debiopharm, SunRock sign agreement for cancer ADCs

What's Your Reaction?

0

Like

0

Dislike

0

Love

0

Funny

0

Angry

0

Sad

0

Wow

Related Posts

Addressing industry challenges through flexible, personalized eCOA solutions

Addressing industry challenges through flexible, person...

Aug 9, 2024

Opinion: Home blood pressure machines are often wrong. The FDA must speak up

Opinion: Home blood pressure machines are often wrong. ...

Aug 15, 2023

CTX-310 by CRISPR Therapeutics for Heterozygous familia...

Jul 6, 2024